Daesung Microbiological Labs. Co., Ltd.

KOSDAQ:A036480 Stock Report

Market Cap: ₩40.2b

Daesung Microbiological Labs Dividend

Dividend criteria checks 0/6

Daesung Microbiological Labs is a dividend paying company with a current yield of 0.71%.

Key information

0.7%

Dividend yield

n/a

Payout ratio

Industry average yield0.6%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-₩178.86
Dividend yield forecast in 3Yn/a

Recent dividend updates

Recent updates

Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?

May 08
Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?

Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Mar 15
Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability

Feb 17
We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability

Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?

Jan 21
Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?

Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years

Dec 31
Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years

Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Dec 10
Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 19
Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, A036480 has been paying a dividend for less than 10 years.

Growing Dividend: A036480 has only been paying a dividend for 2 years, and since then payments have not increased.


Dividend Yield vs Market

Daesung Microbiological Labs Dividend Yield vs Market
How does A036480 dividend yield compare to the market?
SegmentDividend Yield
Company (A036480)0.7%
Market Bottom 25% (KR)1.0%
Market Top 25% (KR)3.6%
Industry Average (Biotechs)0.6%
Analyst forecast in 3 Years (A036480)n/a

Notable Dividend: A036480's dividend (0.71%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.02%).

High Dividend: A036480's dividend (0.71%) is low compared to the top 25% of dividend payers in the KR market (3.55%).


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A036480's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: A036480 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.